13
Views
12
CrossRef citations to date
0
Altmetric
Articles

Autonomic nervous function and baroreflex sensitivity in hypertensive diabetic patients

, PhD, , PhD, , MD, , PhD, , PhD, , PhD, , PhD & , PhD show all
Pages 465-470 | Received 23 Sep 2010, Accepted 22 Feb 2011, Published online: 23 May 2017

References

  • Kardos A, Watterich G, de Menezes R, Csankly M, Casadei B, Rudas LDeterminants of spontaneous baroreflex sensitivity in a healthy working population. Hypertension 2001; 37:911–6.
  • Liao D, Cai J, Barnes RW, Tyroler HA, Rautaharju P. Holme I, Heiss G. Association of cardiac autonomic function and the development of hypertension: the ARIC study. Am J Hypertens 1996; 9:1147–56.
  • Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17(3): 354–81.
  • Ewing DJ, Marlyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985: 8(5): 491–8.
  • Parati G, Di Rienzo M, Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 2001; 19(I): 157-61.
  • Bertinieri G, DiRienzo M, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G.Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol 1988; 254: H377–83.
  • Zhou L, Yu M, Zhu X, Fan H, Cheng M, Shen Z, Duan W. Correlation of spectral analysis of heart rate fluctuations with classical cardiovascular autonomic function tests in NIDDM patients. Chinese J Diabetes 1997; 15:110–11.
  • Pagani M. Heart rate variability and autonomic diabetic neuropathy. Diabetes Nutr Metab 2000; 13(6): 341–6.
  • Whitworth JA, Chalmers J. World health organization-international society ofhypertension (WHO / ISH) hypertension guidelines. Clin Exp Hypertens 2004; 26: 747–52.
  • Wu G, Wu Y, Sheng L, Tang D, Zhao N. Impairment of baroreflex sensitivity in hypertensive patients. J Shanghai Med Univ 1999; 3: 172-5 [in Chinese].
  • Sleight P.The importance of the autonomic nervous system in health and disease. AustNZJMed 1997; 27:467–73.
  • Parmer RI, Cervenka JH, Stone RA.Baroreflex sensitivity and heredity in essential hypertension. Circulation 1992; 85: 497–503.
  • Huang Y, Zhou LN, Wu GC), Dong XH, Hu RM. Detecting diabetic cardiovascular autonomic neuropathy by power spectral analysis of heart rate variability (HRV), baroreflex sensitivity (BRS) and blood pressure variability (BPV) in hypertensive and normotensivediabetic patients. Chinese Journal of Diabetes 2009; 1:46-8 [in Chinese].
  • Takahashi N, Nakagawa M, Saikawa T, Ooie T, Yufu K, Shigematsu S. Hara M, Sakino H, Katsuragi I, Okeda T, Yoshimatsu H, Sakata T. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients. J Am Coll Cardiol 2001; 38(1): 232–7.
  • Pagani M, Malfatto G, Pierini 5, Casati R, Masu AM, Poll M, Guzzetti 5, Lombardi F, Cerutti 5, Malliani A. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv System 1988; 23: 143–53.
  • Singh JP, Larson MG, O’Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, Levy D. Association of hyperglycemia with reduced heart ratevariability (The Framingham Heart Study). Am J Cardiol 2000; 86: 309–12.
  • Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Unsimies EA, Uusitupa MI, Laakso M. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes 1999; 48(6): 1295–9.
  • Frontoni 5, Bracaglia D, Baroni A, Pellegrini F, Perna M, Cicconetti E, Ciampittiello G, Menzinger G, Gambardella S.Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients. Hypertension 2003; 41: 1223–7.
  • Skrapari I, Tentolouris N, Katsilambros N. Baroreflex function: determinants in healthy subjects and disturbances in diabetes, obesity and metabolic syndrome. Curr Diabetes Review 2006; 2: 329–38.
  • Haider AW, Larson MG. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham heart study. Ann Intern Med 2003; 138: 10–6.
  • Bakris GL, Fonseca V. Katholi RE, Mcgill JB, Messerli FH, Phillips RA, Raskin P. Wright JT, Oakes R, Lukas MA, Anderson KM, Bell DS. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 2004, 292: 2227–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.